EUVIMEDOpdag EUVIMED
Übersichtsarbeit

Adjunctive antimicrobials and host modulators in nonsurgical periodontal therapy: Focus on patients with diabetes and smokers

Poliana Mendes Duarte iD, Rafael Lazarin iD, Nathalia Vilela iD, Magda Feres iD

Periodontology 2000 · 2025-11-14

DOI: 10.1111/prd.70020 ↗

At a glance

Übersichtsarbeit in Periodontology 2000, published online on 2025-11-14. Written by Poliana Mendes Duarte and 3 co-authors. Institution: Department of Periodontology, University of Florida College of Dentistry, Gainesville, Florida, USA. Cited 6 times so far (Crossref); 224 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Smoking and diabetes mellitus (DM) are major risk factors for periodontitis, often leading to greater disease severity and reduced response to scaling and root planing (SRP). Consequently, adjunctive therapies have been explored to enhance treatment outcomes in these high‐risk populations. Given that periodontitis is an infectious‐inflammatory disease, both antimicrobial and host‐modulating agents have been proposed as adjuncts to support mechanical debridement. This narrative review critically evaluates clinical evidence from randomized clinical trials and systematic reviews assessing the efficacy of these adjuncts in the nonsurgical management of periodontitis in smokers and patients with DM. Local antimicrobials have shown site‐specific clinical benefits like probing depth reduction and clinical attachment gain, particularly in deep pockets, although microbiological evidence is limited. Systemic antimicrobials, particularly the amoxicillin‐metronidazole combination, demonstrated sustained clinical and microbiological improvements, especially in diabetic patients. Among host‐modulating strategies, sub‐antimicrobial dose doxycycline and locally delivered statins have shown promising effects, though high‐quality, long‐term evidence is still lacking. Adjunctive therapies may improve periodontal treatment outcomes in high‐risk populations, particularly in cases of severe disease. Nonetheless, significant heterogeneity in study design, outcome assessment, and risk factor control limits the generalizability of current findings. Future research should prioritize rigorous methodology, stratified analyses, and the use of clinically meaningful endpoints to better inform evidence‐based decisions on adjunctive therapies in patients with risk factors.

Subjects

Author keywords

antibacterial agentsantioxidantsdiabetes mellitushydroxymethylglutaryl‐coa reductase inhibitorsmetforminperiodontitisrisk factorssmoking

Authors and institutions

  • Department of Periodontology, University of Florida College of Dentistry, Gainesville, Florida, USA.
  • Division of Periodontology, Department of Stomatology, School of Dentistry, University of São Paulo, São Paulo, SP, Brazil.
  • Department of Oral Medicine, Infection, and Immunity, Harvard School of Dental Medicine, Boston, Massachusetts, USA.

ORCID profiles: Poliana Mendes Duarte, Rafael Lazarin, Nathalia Vilela, Magda Feres

Cite

APA

Duarte, P. M., Lazarin, R., Vilela, N., & Feres, M. (2025). Adjunctive antimicrobials and host modulators in nonsurgical periodontal therapy: Focus on patients with diabetes and smokers. Periodontology 2000. https://doi.org/10.1111/prd.70020

Vancouver

Duarte PM, Lazarin R, Vilela N, Feres M. Adjunctive antimicrobials and host modulators in nonsurgical periodontal therapy: Focus on patients with diabetes and smokers. Periodontology 2000. 2025. doi:10.1111/prd.70020

BibTeX
@article{Duarte2025,
  author = {Duarte, Poliana Mendes and Lazarin, Rafael and Vilela, Nathalia and Feres, Magda},
  title = {Adjunctive antimicrobials and host modulators in nonsurgical periodontal therapy: Focus on patients with diabetes and smokers},
  journal = {Periodontology 2000},
  year = {2025},
  doi = {10.1111/prd.70020}
}
Start for free →